CSL 2025 Annual Report

Leadership team CSL’s Global Leadership Group is responsible for driving company performance so that it can keep CSL’s promises to its patients, employees and shareholders. They have earned their roles because of their experience, achievements, unwavering ethics and commitment to CSL’s core values. From 20 September 2024 until 4 March 2025, Andy Schmeltz, Executive Vice President, CSL Behring took a temporary period of caregiver leave. During this period, Joy Linton served as Interim, Executive Vice President, CSL Behring, while John Levy served as Interim Chief Financial Officer. + READ MORE AT CSL.COM/WE-ARE-CSL/ OUR LEADERSHIP#GLG Paul McKenzie PhD (Chemical Engineering) Age 59 Chief Executive Officer and Managing Director Dr McKenzie was appointed Chief Executive Officer and Managing Director of CSL Limited on 6 March 2023. After joining CSL as Chief Operating Officer in 2019, Dr McKenzie became accountable for optimising CSL’s operations as well as growing the CSL Seqirus, CSL Plasma, and CSL Vifor businesses. Prior to joining CSL, Dr McKenzie was Executive Vice President of Pharmaceutical Operations & Technology at Biogen. He also served in a range of progressively senior level roles in R&D and manufacturing at Johnson & Johnson, Bristol‑Myers Squibb and Merck. Joy Linton BComm; F. Fin; GAICD Age 59 Chief Financial Officer Joy Linton was appointed Chief Financial Officer in October 2020. Prior to joining CSL, Joy was chief financial officer and executive director at Bupa, a global health insurance company based in the UK, and earlier served as the General Manager of health services for Bupa UK. Joy has over 30 years’ experience in branded consumer businesses across insurance, healthcare and fast‑moving consumer goods as a global and strategic chief financial officer. Greg Boss JD, BS (Hon) Age 63 Executive Vice President, Legal and CSL Group General Counsel Greg was appointed Group General Counsel in 2009 and is responsible for worldwide legal operations, risk management and compliance for all CSL Group companies. He joined CSL in 2001, serving as General Counsel for what became the CSL Behring business. Prior to joining CSL, Greg was Vice President and Senior Counsel for CB Richard Ellis International, after spending 10 years in private legal practice focusing on corporate and securities law. Hervé Gisserot IEP (Institut d’Études Politiques de Paris (SciencePo). Age 60 Senior Vice President and General Manager CSL Vifor Hervé Gisserot was appointed Senior Vice President and General Manager of CSL Vifor in March 2023. He is responsible for the global CSL Vifor Business unit strategy and operations, leading a team of approx. 2,000 professionals. Prior to being appointed to his current role, Hervé was Chief Commercial Officer and member of the Executive Committee of Vifor Pharma. Hervé brings extensive commercial experience gained in leadership roles at major healthcare companies around the world. 46 Governance

RkJQdWJsaXNoZXIy MjE2NDg3